Prognostic factors in advanced multiple myeloma patients treated with the association of bortezomib, melphalan, prednisone and thalidomide (VMPT)

被引：0
|
作者：
Palumbo, A. [1 ]
Gay, F. [1 ]
Ambrosini, M. T. [1 ]
Benevolo, G. [2 ]
Pregno, F. [2 ]
Pescosta, N.
Callea, V [3 ]
Cangialosi, C. [4 ]
Caravita, T. [5 ]
Morabito, F. [6 ]
Musto, P. [7 ]
Larocca, A. [1 ]
Caltagirone, S. [1 ]
Avonto, I [1 ]
Cavallo, F. [1 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Turin, Az Osp S Giovanni Battista, Div Ematol, Turin, Italy
[2] Azienda Osped San Giovanni Battista, Turin, Italy
[3] Osped Riuniti Bergamo, Div Ematol, Reggio Di Calabria, Italy
[4] Azienda Osped Cervello, Div Ematol Trapianto Midollo Osseo, Palermo, Italy
[5] Univ Roma Tor Vergata, Osped San Eugenio, Cattedra & Div Ematol, Rome, Italy
[6] Azienda Osped Cosenza, UOC Ematol, Cosenza, Italy
[7] UOC Ematol Trapianto Cellule Staminali, CROB, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Factors predictive of outcome in relapsed, refractory multiple myeloma patients treated with bortezomib, melphalan, prednisone, and thalidomide (VMPT)
    Palumbo, A. P.
    Ambrosini, M. T.
    Benevolo, G.
    Pescosta, N.
    Callea, V.
    Cangialosi, C.
    Caravita, T.
    Morabito, F.
    Gay, F.
    Boccadoro, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Olivero, Barbara
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Zambello, Renato
    Cangialosi, Clotilde
    Pietrantuono, Giuseppe
    Magarotto, Valeria
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Ciccone, Giovannino
    Di Raimondo, Francesco
    Gaidano, Gianluca
    Boccadoro, Mario
    BLOOD, 2009, 114 (22) : 58 - 58
  • [3] Bortezomib, melphalan, prednisone, and thalidomide (VMPT) followed by maintenance with bortezomib and thalidomide (VT) for initial treatment of elderly multiple myeloma patients
    Boccadoro, M.
    Bringhen, S.
    Gaidano, G.
    Ria, R.
    Offidani, M.
    Patriarca, F.
    Nozzoli, C.
    Musto, P.
    Petrucci, M.
    Palumbo, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors
    Palumbo, Antonio
    Bringhen, Sara
    Cavalli, Maide
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Zambello, Renato
    Pietrantuono, Giuseppe
    De Rosa, Luca
    Liberati, Anna Marina
    Crippa, Claudia
    Perrone, Giulia
    Ciambelli, Fabrizio
    Carella, Angelo Michele
    Palmieri, Salvatore
    Gilestro, Milena
    Magarotto, Valeria
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Gaidano, Gianluca
    Boccadoro, Mario
    BLOOD, 2010, 116 (21) : 272 - 273
  • [5] Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Pellegrino
    Bringhen, Sara
    Falco, Patrizia
    Avonto, Ilaria
    Cavallo, Federica
    Boccadoro, Mario
    BLOOD, 2007, 109 (07) : 2767 - 2772
  • [6] BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT) VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) IN ELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE, RANDOMIZED, PHASE III STUDY
    Palumbo, A.
    Bringhen, S.
    Rossi, D.
    Ria, R.
    Berretta, S.
    Offidani, M.
    Patriarca, F.
    Nozzoli, C.
    Levi, A.
    Guglielmelli, T.
    Benevolo, G.
    Callea, V.
    Liberati, A. M.
    Crippa, C.
    Di Renzo, N.
    Catalano, L.
    De Sabbata, G.
    Rizzi, R.
    Feo, C.
    Mazza, R.
    Farina, G.
    Spadano, A.
    Pisani, F.
    Podda, L.
    Aitoro, G.
    Magarotto, V.
    Astolfi, M.
    Di Raimondo, F.
    Gaidano, G.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 190 - 191
  • [7] Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Dmide
    Cavalli, Maide
    Ria, Roberto
    Gentilini, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Vincelli, Donatella
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Pautasso, Chiara
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Cangialosi, Clotilde
    Mansueto, Giovanna
    Liberati, Anna Marina
    Magarotto, Valeria
    Omede, Paola
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Boccadoro, Mario
    BLOOD, 2012, 120 (21)
  • [8] A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Magarotto, Valeria
    Di Raimondo, Francesco
    Ria, Roberto
    Offidani, Massimo
    Nozzoli, Chiara
    Patriarca, Francesca
    Callea, Vincenzo
    Benevolo, Giulia
    Marasca, Roberto
    Guglielmelli, Tommasina
    Rizzo, Manuela
    Grasso, Mariella
    Petrucci, Maria Teresa
    Omede, Paola
    Gaidano, Gianluca
    Boccadoro, Mario
    BLOOD, 2008, 112 (11) : 243 - 243
  • [9] Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
    Morabito, Fortunato
    Gentile, Massimo
    Mazzone, Carla
    Rossi, Davide
    Di Raimondo, Francesco
    Bringhen, Sara
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Petrucci, Maria Teresa
    Benevolo, Giulia
    Vincelli, Iolanda
    Guglielmelli, Tommasina
    Grasso, Mariella
    Marasca, Roberto
    Baldini, Luca
    Montefusco, Vittorio
    Musto, Pellegrino
    Cascavilla, Nicola
    Majolino, Ignazio
    Musolino, Caterina
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2011, 118 (22) : 5759 - 5766
  • [10] Combination of bortezomib, melphalan, prednisone and thalidomide (VMPT) for relapsed multiple myeloma: Results of a phase I/II clinical trial.
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Legrino
    Bringhen, Sara
    Gay, Francesca
    Rus, Cecilia
    Boccadoro, Mario
    BLOOD, 2006, 108 (11) : 125A - 125A
12345